Page 9 - Double Blind Study News Today

Efficacy and safety of the two formulations were directly compared in a randomized, controlled, double-blind study of men with AGA conducted in Brazil.

New estimates suggest that more adults with cancer are participating in cancer trial research, especially at National Cancer Institute–designated centers, but overall enrollment rates remain low.

Prescribing medication for alcohol use disorder on hospital discharge was associated with a significant decrease in the risk for an alcohol-related rehospitalization.

Monthly cycles of a 5-day FMD (plant-based, low-calorie, and low-protein) followed by a normal diet appeared to improve markers of prediabetes and immune system aging.

Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.

Higher consumption of ultraprocessed food is tied to long-term risk of developing irritable bowel syndrome.

While the hepatitis E virus causes tens of thousands of deaths each year, data suggest that a vaccine approved in China has long-term efficacy.

A mobile application improved erectile function during a 12-week trial, researchers report.

Cognitive assessments administered via a smartphone app proved accurate and reliable in detecting frontotemporal dementia in high-risk individuals.

Alopecia, dysesthesia, and other types of skin sensations have been reported in patients treated with semaglutide, but more research is needed to understand skin findings associated with this drug.